Duchenne Muscular Dystrophy:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Duchenne Muscular Dystrophy 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Duchenne Muscular Dystrophy 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Duchenne Muscular Dystrophy Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
PTC Therapeutics, Inc. 33
Clinical Trial Overview of PTC Therapeutics, Inc. 33
Prosensa Therapeutics B.V. 34
Clinical Trial Overview of Prosensa Therapeutics B.V. 34
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Sarepta Therapeutics, Inc. 36
Clinical Trial Overview of Sarepta Therapeutics, Inc. 36
Acceleron Pharma, Inc. 37
Clinical Trial Overview of Acceleron Pharma, Inc. 37
Santhera Pharmaceuticals Holding AG 38
Clinical Trial Overview of Santhera Pharmaceuticals Holding AG 38
Summit Corporation plc 39
Clinical Trial Overview of Summit Corporation plc 39
GlaxoSmithKline Inc. 40
Clinical Trial Overview of GlaxoSmithKline Inc. 40
Halo Therapeutics, LLC 41
Clinical Trial Overview of Halo Therapeutics, LLC 41
DART Therapeutics, LLC 42
Clinical Trial Overview of DART Therapeutics, LLC 42
Cardoz AB 43
Clinical Trial Overview of Cardoz AB 43
Summit plc 44
Clinical Trial Overview of Summit plc 44
Catabasis Pharmaceuticals, Inc. 45
Clinical Trial Overview of Catabasis Pharmaceuticals, Inc. 45
Action Duchenne 46
Clinical Trial Overview of Action Duchenne 46
Asklepios BioPharmaceutical, Inc. 47
Clinical Trial Overview of Asklepios BioPharmaceutical, Inc. 47
Italfarmaco S.A. 48
Clinical Trial Overview of Italfarmaco S.A. 48
GlaxoSmithKline AG 49
Clinical Trial Overview of GlaxoSmithKline AG 49
Shenzhen Beike Biotechnology Co., Ltd. 50
Clinical Trial Overview of Shenzhen Beike Biotechnology Co., Ltd. 50
Galapagos NV 51
Clinical Trial Overview of Galapagos NV 51
NicOx S.A. 52
Clinical Trial Overview of NicOx S.A. 52
Clinical Trial Overview of Top Institutes / Government 53
Cooperative International Neuromuscular Research Group 53
Clinical Trial Overview of Cooperative International Neuromuscular Research Group 53
Kobe University 54
Clinical Trial Overview of Kobe University 54
Nationwide Children’s Hospital 55
Clinical Trial Overview of Nationwide Children’s Hospital 55
Cedars-Sinai Medical Center 56
Clinical Trial Overview of Cedars-Sinai Medical Center 56
National Institute of Neurological Disorders and Stroke 57
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 57
National Center for Research Resources 58
Clinical Trial Overview of National Center for Research Resources 58
University Hospital Freiburg 59
Clinical Trial Overview of University Hospital Freiburg 59
Assistance Publique – Hopitaux de Paris 60
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 60
Cincinnati Children’s Hospital Medical Center 61
Clinical Trial Overview of Cincinnati Children’s Hospital Medical Center 61
Genethon 62
Clinical Trial Overview of Genethon 62
The Royal Children’s Hospital 63
Clinical Trial Overview of The Royal Children’s Hospital 63
National Human Genome Research Institute 64
Clinical Trial Overview of National Human Genome Research Institute 64
Radboud University Nijmegen Medical Centre 65
Clinical Trial Overview of Radboud University Nijmegen Medical Centre 65
Chaitanya Hospital 66
Clinical Trial Overview of Chaitanya Hospital 66
Boston Children’s Hospital 67
Clinical Trial Overview of Boston Children’s Hospital 67
The University of North Carolina 68
Clinical Trial Overview of The University of North Carolina 68
National Heart, Lung, and Blood Institute 69
Clinical Trial Overview of National Heart, Lung, and Blood Institute 69
Catholic University of the Sacred Heart 70
Clinical Trial Overview of Catholic University of the Sacred Heart 70
Imperial College London 71
Clinical Trial Overview of Imperial College London 71
Shriners Hospitals for Children 72
Clinical Trial Overview of Shriners Hospitals for Children 72
Five Key Clinical Profiles 73
Appendix 131
Abbreviations 131
Definitions 131
Research Methodology 132
Secondary Research 132
About GlobalData 133
Contact Us 133
Disclaimer 133
Source 134


【レポート販売概要】

■ タイトル:Duchenne Muscular Dystrophy:グローバル臨床試験レビューH2, 2013
■ 英文:Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2013
■ 発行日:2013年8月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161760
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。